Revelation Biosciences (Petra Acquisition) ^{Priced, Nasdaq: REVB}

We are a blank check company formed under the laws of the State of Delaware on November 20, 2019. We were formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. To date, our efforts have been limited to organizational activities as well as activities related to this offering. Our initial business combination and value creation strategy will be to identify, acquire and, after our initial business combination, assist in the growth of a business in the healthcare or a healthcare-related industry. While we may pursue an initial business combination opportunity in any business, industry, sector or geographical location, we intend to initially focus our search on identifying a prospective target business in the healthcare or healthcare-related industry in the United States and other developed countries. Our strategy will be to identify, acquire and, after our initial business combination, build, a healthcare or a healthcare-related business. We intend to focus our investment effort broadly across the entire healthcare industry, which encompasses services, therapeutics, devices, diagnostics and animal health and services. We intend to seek initial business combination targets with smaller enterprise values and to particularly focus on the life sciences, medical technology, digital health and technology-enabled services sectors.